Should Biotechnology Stock Harpoon Therapeutics Inc (HARP) Be in Your Portfolio Monday?

Monday, March 11, 2024 12:14 PM | InvestorsObserver Analysts

Mentioned in this article

Should Biotechnology Stock Harpoon Therapeutics Inc (HARP) Be in Your Portfolio Monday?

A rating of 79 puts Harpoon Therapeutics Inc (HARP) near the top of the Biotechnology industry according to InvestorsObserver. Harpoon Therapeutics Inc's score of 79 means it scores higher than 79% of stocks in the industry. Harpoon Therapeutics Inc also received an overall rating of 69, putting it above 69% of all stocks. Biotechnology is ranked 18 out of the 148 industries.

HARP has an Overall Score of 69. Find out what this means to you and get the rest of the rankings on HARP!

See Full HARP Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 69 would rank higher than 69 percent of all stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Harpoon Therapeutics Inc Stock Today?

Harpoon Therapeutics Inc (HARP) stock is flat 0% while the S&P 500 is lower by -0.26% as of 4:00 PM on Friday, Mar 8. HARP is flat $0.00 from the previous closing price of $23.01 on volume of 0 shares. Over the past year the S&P 500 is higher by 32.53% while HARP has risen 243.43%. HARP lost -$8.71 per share the over the last 12 months. Click Here to get the full Stock Report for Harpoon Therapeutics Inc stock.